Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Combined With ICIs for Unresectable Stage III NSCLC
NCT06031597Phase 3Not yet recruiting
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Sep 2023
- Primary completion
- Dec 2025
01
Overview
Phase 3, open-label trial in non-small cell lung cancer (NSCLC) (3 cohorts), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Radiation Pneumonitis at 6 months. Planned start Sep 2023; status: not yet recruiting.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT06031597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06031597.